FDA recalls Axcil and Desirin

Sep 24, 2007

The U.S. Food and Drug Administration announced the recall of two sexual enhancement products -- Axcil and Desirin -- because of undeclared, ingredients.

Axcil -- described as a "male enhancement" product -- and Desirin -- said to "promote female sexual function" -- are over-the-counter drugs distributed nationwide by TWC Global LLC of Mountain View Calif. The company initiated the voluntary recall after FDA tests found the products contain sildenafil, the active ingredient of a FDA-approved drug to treat erectile dysfunction, as well as two analogs -- sulfosildenafil and sulfohomosildenafil.

The FDA said the undeclared chemicals pose a threat to consumers because they might interact with nitrates found in some prescription drugs.

Both Axcil and Desirin are sold via the Internet in a 15-capsule blister pack packaged in a box.

Consumers with questions can contact the company at 650-575-0828.

Copyright 2007 by United Press International

Explore further: New research demonstrates benefits of national and international device registries

add to favorites email to friend print save as pdf

Related Stories

Recommended for you

New approach to particle therapy dosimetry

13 hours ago

Researchers at the National Physical Laboratory (NPL), in collaboration with EMRP partners, are working towards a universal approach to particle beam therapy dosimetry.

Supplement maker admits lying about ingredients

Dec 17, 2014

Federal prosecutors say the owner and president of a dietary supplement company has admitted his role in the sale of diluted and adulterated dietary ingredients and supplements sold by his company.

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.